DATASET RE-READ 2026-11-2042 PROGRAMSNEXLIFE PRICES READ 2026-11-20EVERY FIGURE CARRIES ITS READ DATE
TopGLP1Providers.comverified price index
DATED PRICES

Hims & Hers tirzepatide: November 2026 price and position

As of November 20, 2026, Hims & Hers is a brand route for tirzepatide: its page refused automated reads on November 20, 2026 (HTTP 403); Lilly's November 6, 2026 release says Hims patients can buy Zepbound from $299 and Foundayo from $149 at Lilly's self-pay prices, with no Hims fee stated. It sells or prescribes brand medication rather than compounded tirzepatide, so it has no place in this site’s compounded tirzepatide comparison.

Released · Last reviewed · how we verify

Check Hims & Hers’s tirzepatide price ↗

Brand prices for comparison

Bought direct, Zepbound vials cost $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5–15 mg when each refill is within 45 days (otherwise $499 at 7.5 mg and $699 at 10–15 mg); Wegovy pens cost $349 a month and the Wegovy pill $149 to $299 by dose (NovoCare, read November 20, 2026; the Zepbound ladder is carried from October 15 because lilly.com refused automated reads). See the brand price page.

FDA warning letters

FDA’s warning-letter index lists warning letter 716567 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) and warning letter 716825 (dated September 9, 2025, subject “Unlawful Sale of Unapproved and Misbranded Drugs to United States Consumers Over the Internet (Telehealth)”) to Hims & Hers; no close-out letter is listed. A warning letter is FDA’s formal notice of alleged violations, not a recall, ban or court finding.

Limitations and what to check before you enroll

Brand Zepbound is FDA-approved. Through Hims & Hers you pay the manufacturer’s self-pay price, or your insurance copay, plus any fee Hims & Hers charges for its own service. Ask for that fee, what it includes and how it renews before you start. A clinician decides whether any GLP-1 is right for you.

Frequently asked

How much does Hims & Hers charge for tirzepatide?

As of November 20, 2026, Hims & Hers is a brand route for tirzepatide: its page refused automated reads on November 20, 2026 (HTTP 403); Lilly's November 6, 2026 release says Hims patients can buy Zepbound from $299 and Foundayo from $149 at Lilly's self-pay prices, with no Hims fee stated. It sells or prescribes brand medication rather than compounded tirzepatide, so it has no place in this site’s compounded tirzepatide comparison.

Is Hims & Hers’s tirzepatide FDA-approved?

Hims & Hers is a brand route: the brand medication it offers (Zepbound) is FDA-approved. Compounded tirzepatide from other programs is not FDA-approved and is not the same product.

Where do these Hims & Hers figures come from?

From Hims & Hers’s own page (not readable Nov 20, November 20, 2026), converted to an all-in month-to-month figure (medication plus any required recurring fee, before tax). The source link and read date are listed below, and the same figures are in the open dataset.

Hims & Hers reviewHims & Hers semaglutideTirzepatide price tableCheapest tirzepatide providersRankings

Sources

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.